Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112521482A reveals a solid-liquid combined method for nesiritide. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Patent CN112062811A details a green electrochemical method for Vilacatide. Achieve high purity and cost reduction in peptide API manufacturing with scalable solid-phase technology.
Patent CN106701698B reveals high-efficiency SsCR enzyme for chiral alcohol synthesis. Achieves 99.9% ee and 500mmol/L substrate concentration for scalable manufacturing.
Novel semi-synthetic process for taxane derivatives using activated oxazoles. Offers improved yield and purity for API manufacturing.
This patent details a novel 3-fluoro-5-iodoaniline synthesis using 3,4-difluoronitrobenzene. It achieves 61.9% total yield without column purification, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel solid-phase synthesis method for Omega-Conotoxin GVIA. Enhances disulfide bond accuracy and yield for pharmaceutical intermediates supply chain.
Novel patent CN103664887B enables high-purity Esomeprazole Sodium production. Eliminating toxic solvents ensures cost reduction and supply chain reliability for global pharmaceutical partners.
Novel synthesis process offers high purity and yield for pharmaceutical intermediates supply chain stability and cost efficiency.
Patent CN110467557A reveals a high-yield one-pot synthesis for Apremilast. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel purification protocol enhances tildipirosin purity and yield while reducing costs for veterinary pharmaceutical supply chains globally ensuring stable availability.
Novel transfer hydrogenation method for chiral hydroxycyclobutenone. Offers high selectivity, mild conditions, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103214487A reveals stable synthesis route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel patent CN115109104B offers mild conditions and reduced purification steps for cordycepin, ensuring supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN115536663A reveals a cost-effective synthesis for Trilaciclib intermediates. Discover optimized routes for high-purity API manufacturing and supply chain stability.
Patent CN120665091A reveals one-step indole biaryl synthesis reducing cost and improving supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN103387500A reveals a mild catalytic route for Mirabegron intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel copper-catalyzed route reduces costs and improves purity for insomnia drug intermediates, ensuring supply chain stability and commercial scalability.
Advanced synthesis of ethyl 4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]benzoate. Cost-effective, scalable nilotinib intermediate manufacturing with high yield.
Novel preparation method for Silodosin intermediate via CN104974072A. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN106660949B reveals a safe, scalable chiral resolution method for TRPV1 antagonist intermediates, offering significant cost reduction in API manufacturing.